中紀委:反壟斷沒有禁區 沒有例外
中紀委發布文章《深度關注-給資本擴張設置紅綠燈》稱,早前包括騰訊(00700.HK)、美團(03690.HK)、阿里巴巴(09988.HK)等互聯網平台企業,分別接受了反壟斷監管機構的立案調查或處罰。
文章指出,反壟斷沒有禁區,沒有例外。強化反壟斷、深入推進公平競爭政策,不僅僅關乎「聽歌自由」、「平台選擇自由」、「付款方式自由」,更關乎保護消費者權益,市場公平競爭與健康發展。只有破除壟斷,才能充分激發市場主體創新活力和發展動力,進一步提高內地企業的整體競爭力。短期來看,一系列反壟斷監管措施的出台對互聯網巨頭有影響,但長期看是最好的選擇。(ta/w)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.